The costs of chronic kidney disease in Russian Federation

Background. The chronic kidney disease (CKD) is one of the leading causes of disability and mortality and the main challenges for health care. Objective. To assess medical costs attributable to CKD from the position of public health payer in Russian federation. methods. we modelled the ckd costs depending on disease stage. the number of medical services provided and administered drugs were defined based on clinical guidelines and published Russian and international research. The price for medical services was based on public health insurance tariffs and for drugs - on governmental procurement. The total amount and structure of costs for the whole population were evaluated based on the prevalence according to the number of diagnoses registered during outpatient medical encounters and expected prevalence according to the epidemiologic research. Findings. The annual medical cost per patient covered by the public health payer varied from 0,87 thousand RUR at stage 1 to 20,97 thousand rur at stage 4, reaching 945,01 thousand rur at stage 5. the total costs for the whole population were estimated between 111,9 - 200 bln rur, depending on the chosen approach to estimate the prevalence, with the number of patients at stage 5 and renal replacement therapy being the main cost drivers. Conclusion. The average annual costs per patient with ckd stage 5 are above 950 thousand rur, surpassing the costs of stages 1 - 4 more than 20 times. Thus, it appears highly probable that costs of interventions aimed at controlling and slowing down the ckd progression would be compensated by decreasing the late-stage costs.

chronic kidney disease, medical costs